Use of Organs from SARS-CoV-2 Infected Donors: Is It Safe? A Contemporary Review
Autor: | Vivek B Kute, Krista L. Lentine, Hari Shankar Meshram, Vidya A. Fleetwood, Alexis Guenette |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Immunology Organ donation Pandemic medicine Living donors Intensive care medicine COVID19 and Transplantation (R Avery Section Editor) Deceased donors Transplantation Hepatology SARS-CoV-2 business.industry Transmission (medicine) Public health Organ dysfunction COVID-19 Vaccination Nephrology Screening Surgery medicine.symptom business |
Zdroj: | Current Transplantation Reports |
ISSN: | 2196-3029 |
DOI: | 10.1007/s40472-021-00343-0 |
Popis: | Purpose of Review As the prevalence of individuals with recovered coronavirus disease 2019 (COVID-19) increases, determining if and when organs from these donors can be safely used is an important priority. We examined current knowledge of outcomes of transplant using donors with recovered COVID-19. Recent Findings A literature search of PubMed and Google scholar databases was conducted to identify articles with terms “SARS-CoV2,” “COVID-19,” “donor recovered,” and “transplantation” published through 08/10/2021. We identified 25 reports detailing 94 recipients of both abdominal and thoracic transplants from donors with both prior and active COVID-19 infection. Rates of transmission to the recipient and of transplanted organ dysfunction were low among reports of donors with prior COVID-19 infection. End organ dysfunction and transmission were more common with active infection, although few reports are available. Standardized reporting is needed to better assess the impact of donor symptomatology, cycle thresholds, and individual recipient risk factors on postoperative outcomes. Summary Available reports suggest that transplantation from COVID-19 donors may be feasible and safe, at least in short term follow-up. Nevertheless, there is a need for standardized testing and management protocols which should be tailored for available resources. While increased availability of COVID-19 vaccinations will mitigate risks of donor-derived COVID-19 and simplify management, continued vigilance is warranted during the ongoing public health emergency. |
Databáze: | OpenAIRE |
Externí odkaz: |